Stock LPCN LIPOCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Lipocine Inc.

Equities

LPCN

US53630X2036

Delayed Nasdaq
Other stock markets
 19:01:27 06/05/2024 BST 		5-day change 1st Jan Change
5.09 USD +8.77% Intraday chart for Lipocine Inc. +6.55% +80.65%
05-01 Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 CI
04-12 Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LIPOCINE : HC Wainwright Adjusts Lipocine's Price Target to $3.50 From $2.50, Keeps Buy Rating
MT
LIPOCINE : Cantor Fitzgerald Starts Lipocine at Overweight With $3 Price Target
MT
LIPOCINE : Ladenburg Thalmann Adjusts Lipocine's Price Target to $2.50 From $3, Maintains Buy Rating
MT
LIPOCINE : HC Wainwright Adjusts Price Target for Lipocine to $2.50 From $3, Maintains Buy Rating
MT
LIPOCINE : Ladenburg Thalmann Upgrades Lipocine to Buy From Neutral, $3 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LPCN Stock
  4. News Lipocine Inc.
  5. Analyst Reco.